Amin Alishahi, MD
Pain Medicine · Sun City, AZNPI 1568806107
Payments from drug & device makers
Across 355 payments — averaging $26.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$922
- Nevro Corp.$608
- UCB, Inc.$603
- AbbVie$394
- Amneal Pharmaceuticals LLC$366
- plus $3K from 50 others
What the payments were for
- Food & beverage$9,516100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCTRODE$1,003
- PROCLAIM$306
- Senza Spinal Cord Stimulation System$288
- Octrode SCS Leads$282
- PENTA$241
- ETERNA$189
- Proclaim Family of SCS IPGs$177
- Exclaim SCS Leads$158
- Penta SCS Leads$154
- Omnia$137
- INTELLIS$133
- Axium Sheath Braided DRG$110
- INTELLIS ADAPTIVESTIM$106
How this compares
$9,516 in reported general payments places this provider in the 65th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 169 | $3,501 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 114 | $2,202 |
| Pregabalin | 77 | $2,133 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 69 | $1,548 |
| Duloxetine Hcl | 72 | $1,185 |
| Tizanidine Hcl | 87 | $1,023 |
| Cyclobenzaprine Hcl | 64 | $718 |
| Diclofenac Sodium | 31 | $584 |
| Oxycodone Hcl | 42 | $515 |
| Tramadol Hcl | 56 | $408 |
| Baclofen | 15 | $309 |
| Methocarbamol | 16 | $273 |
| Methadone Hcl | 12 | $175 |
| Meloxicam | 56 | $143 |
| Methylprednisolone | 15 | $108 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Sun City
- Gobi ParamanandamPhoenix$2.7M
- Efrain CubilloTucson$694K
- Eric CornidezTucson$581K
- Mohab IbrahimTucson$387K
- Selaiman NooriLake Havasu City$265K
- Tory McJunkinScottsdale$218K
- Minesh ZaveriPhoenix$187K
- Chad PletnickOro Valley$137K
- Tristan PicoChandler$121K
- Daniel KreinerPhoenix$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.